The biotech sponsor needed to demonstrate the safety and tolerability of the lead molecule in healthy volunteers, as well as direct target engagement and biomarker effects for IPF patients in a short space of time.
Caidya Announces Strategic Combination with Simbec-Orion —Â Learn more here
IPF Pharmacology Case Study: Operational Excellence Drives Healthy Volunteer To Patient Cohort Results in 24 Months for Rare Respiratory Disease
